A histological and immunohistochemical investigation to assess the therapeutic role of metformin nanoemulsion against metformin in a diabetic retinopathy model

References

• Sorour OA, Mehta N, Baumal CR, et al. Morphological changes in intraretinal microvascular abnormalities after anti-VEGF therapy visualized on optical coherence tomography angiography. Eye Vis (Lond). 2020;7(1):29. doi: 10.1186/s40662-020-00195-2
   PubMedGoogle Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabet Res Clin Pract. 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond). 2009;23(7):1496–1508. doi: 10.1038/eye.2009.108
   PubMed Web of Science ®Google Scholar
• Jiang T, Chang Q, Cai J, et al. Protective effects of melatonin on retinal inflammation and oxidative stress in experimental diabetic retinopathy. Oxid Med Cell Longev. 2016;2016:3528274. doi: 10.1155/2016/3528274
   PubMed Web of Science ®Google Scholar
• Luippold G, Bedenik J, Voigt A, et al. Short- and longterm glycemic control of streptozotocin-induced diabetic rats using different insulin preparations. PLOS ONE. 2016;11(6):e0156346. doi: 10.1371/journal.pone.0156346
   PubMed Web of Science ®Google Scholar
• Titchenell PM, Antonetti DA. Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy. Diabetes. 2013;62(6):1808–1815. doi: 10.2337/db12-1744
   PubMed Web of Science ®Google Scholar
• Abbasian M, Bighlari P, Mahmoodzadeh F, et al. A de novo formulation of metformin using chitosan-based nanomicelles for potential diabetes therapy. J Appl Polym Sci. 2019;136(41):48037. doi: 10.1002/app.48037
   Web of Science ®Google Scholar
• Bodmer M, Meier C, Krahenbuhl S, et al. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008;31(11):2086–2091. doi: 10.2337/dc08-1171
   PubMed Web of Science ®Google Scholar
• Ilahi I, Asghar A, Ali S, et al. Beneficial effects of Pentanema vestitum Linn. whole plant on the glucose and other biochemical parameters of alloxan induced diabetic rabbits. ISRN Pharmacol. 2012;2012:478023. doi: 10.5402/2012/478023
   PubMedGoogle Scholar
• Hassan NH, Maern S, Saleh D. Does metformin protect against diabetic retinopathy in albino rats? An immunohistochemical study. Cytol & Histol Rep. 2019;2(02):110.
   Google Scholar
• Ibrahim IY, Ali FF, Abdel-Hakeem EA, et al. Pathophysiological mechanisms of type 2 diabetes mellitus and the effects of metformin treatment in adult male albino rats. Minia J Med Res. 2023;34(1):209–214. doi: 10.21608/mjmr.2023.184444.1271
   Google Scholar
• Freichels H, Danhier F, Préat V, et al. Fluorescent labeling of degradable poly(lactide-co-glycolide) for cellular nanoparticles tracking in living cells. Int J Artif Organs. 2011;34(2):152–160. doi: 10.5301/ijao.2011.6420
   PubMed Web of Science ®Google Scholar
• Jia L. Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: Approaches experimental evidences and theory. Curr Nanosci. 2005;1(3):237–243. doi: 10.2174/157341305774642939
   PubMed Web of Science ®Google Scholar
• Liu KC, Yeo Y. Extracellular stability of nanoparticulate drug carriers. Arch Pharm Res. 2014;37(1):16–23. doi: 10.1007/s12272-013-0286-0
   PubMed Web of Science ®Google Scholar
• Albeltagy RS, Hussein MM, Alazzouni AS, et al. Anti-diabetic effects of metformin nanoemulsion and cell-based therapy on the insulin signaling pathway (IRS1/AKT) and apoptotic related genes in type 2 diabetic rat model. Egypt Acad J Of Biol Sci C, Physiol And Mol Biol. 2021;13(1):159–172. doi: 10.21608/eajbsc.2021.178255
   Google Scholar
• Lin C-Y, Chen L-W. Comparison of fuel properties and emission characteristics of two- and three-phase emulsions prepared by ultrasonically vibrating and mechanically homogenizing emulsification methods. Fuel. 2008;87(10–11):2154–2161. doi: 10.1016/j.fuel.2007.12.017
   Web of Science ®Google Scholar
• Rodrigues FVS, Diniz LS, Sousa RMG, et al. PREPARATION and CHARACTERIZATION of NANOEMULSION CONTAINING a NATURAL NAPHTHOQUINONE. Quím Nova. 2018;41:756–761. doi: 10.21577/0100-4042.20170247
   Web of Science ®Google Scholar
• Abdel Aziz MT, Wassef MAA, Ahmed HH, et al. The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy. Diabetol Metab Syndr. 2014;6(1):34. doi: 10.1186/1758-5996-6-34
   PubMedGoogle Scholar
• Bancroft JD, Layton C. The hematoxylins and eosin. Bancroft’s theory and practice of histological techniques. Elsevier; 2019. p. 126–138. doi: 10.1016/B978-0-7020-6864-5.00010-4
   Google Scholar
• Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. Fourth ed. 2008. p. 760–783. doi: 10.1002/9780470773666.refs
   Google Scholar
• Chibber R, Ben-Mahmud BM, Chibber S, et al. Leukocytes in diabetic retinopathy. Curr Diabetes Rev. 2007;3:3–14. doi: 10.2174/157339907779802139
   PubMedGoogle Scholar
• Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30:343–358. doi: 10.1016/j.preteyeres.2011.05.002
   PubMed Web of Science ®Google Scholar
• Yu D-Y, Cringle SJ. Retinal degeneration and local oxygen metabolism. Exp Eye Res. 2005;80(6):745–751. doi: 10.1016/j.exer.2005.01.018
   PubMed Web of Science ®Google Scholar
• Masuda T, Shimazawa M, Hara H. Retinal diseases associated with oxidative stress and the effects of a free radical scavenger (Edaravone). Oxid Med Cell Longev. 2017;2017:9208489. doi: 10.1155/2017/9208489
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Hara H, Kondo M, et al. Oxidative stress in retinal diseases. Oxid Med Cell Longev. 2017;2017:4076518. doi: 10.1155/2017/4076518
   PubMed Web of Science ®Google Scholar
• Rathnasamy G, Foulds WS, Ling E-A, et al. Retinal microglia - a key player in healthy and diseased retina. Prog Neurobiol. 2019;173:18–40. doi: 10.1016/j.pneurobio.2018.05.006
   PubMed Web of Science ®Google Scholar
• Cuenca N, Fernández-Sánchez L, Campello L, et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res. 2014;43:17–75. doi: 10.1016/j.preteyeres.2014.07.001
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Akhlaq A. Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases. Prog Retin Eye Res. 2021;83:100921. doi: 10.1016/j.preteyeres.2020.100921
   PubMed Web of Science ®Google Scholar
• Martin PM, Roon P, Van Ells TK, et al. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45(9):3330–3336. doi: 10.1167/iovs.04-0247
   PubMed Web of Science ®Google Scholar
• Sadek E, Abd-El Fattah L, El Maadawi Z, et al. Simvastatin ameliorates vascular endothelial growth factor overexpression in a rat model of diabetic retinopathy: a histological and immunohistochemical study. Kasr Al Ainy Med J. 2017;23(1):24. doi: 10.4103/2356-8097.207186
   Google Scholar
• Marc RE, Jones BW, Watt CB, et al. Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis. 2008;14:782–806.
   PubMed Web of Science ®Google Scholar
• Foureaux G, Nogueira BS, Coutinho DCO, et al. Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina. Braz J Med Biol Res. 2015;48(12):1109–1114. doi: 10.1590/1414-431X20154583
   PubMed Web of Science ®Google Scholar
• Huang H, Gandhi JK, Zhong X, et al. TNFα is required for late brb breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci. 2011;52(3):1336–1344. doi: 10.1167/iovs.10-5768
   PubMed Web of Science ®Google Scholar
• Moran EP, Wang Z, Chen J, et al. Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications. Am J Physiol Heart Circ Physiol. 2016;311(3):H738–749. doi: 10.1152/ajpheart.00005.2016
   PubMed Web of Science ®Google Scholar
• El-Halim He A, Helal OK, Salem NE, et al. The possible therapeutic effect of mesenchymal stem cells and their exosomes on experimentally induced diabetic retinopathy in rats: Histological and immunohistochemical study. Egypt J Histol. 2020;43:390–411. doi: 10.21608/ejh.2019.18175.1185
   Google Scholar
• Yang Q-H, Zhang Y, Jiang J, et al. Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina. Int J Ophthalmol. 2018;11(6):935–944. doi: 10.18240/ijo.2018.06.07
   PubMed Web of Science ®Google Scholar
• Roy S, Trudeau K, Roy S, et al. Mitochondrial dysfunction and endoplasmic reticulum stress in diabetic retinopathy: mechanistic insights into high glucose-induced retinal cell death. Curr Clin Pharmacol. 2013;8(4):278–284. doi: 10.2174/1574884711308040003
   PubMedGoogle Scholar
• Darnell JE, Lodish HF, Baltimore D. Molecular cell biology. 2nd ed. (NY): Scientific American Books : Distributed by W.H. Freeman; 1990.
   Google Scholar
• Zhou F-Q, Waterman-Storer CM, Cohan CS. Focal loss of actin bundles causes microtubule redistribution and growth cone turning. J Cell Bio. 2002;157(5):839–849. doi: 10.1083/jcb.200112014
   PubMed Web of Science ®Google Scholar
• Lee S, Zeiger A, Maloney JM, et al. Pericyte actomyosin-mediated contraction at the cell–material interface can modulate the microvascular niche. J Phys Condens Matter. 2010;22(19):194115. doi: 10.1088/0953-8984/22/19/194115
   PubMed Web of Science ®Google Scholar
• Hammes H-P, Feng Y, Pfister F, et al. Diabetic retinopathy: targeting vasoregression. Diabetes. 2011;60(1):9–16. doi: 10.2337/db10-0454
   PubMed Web of Science ®Google Scholar
• Cai X, McGinnis JF. Diabetic retinopathy: Animal models, therapies, and perspectives. J Diabetes Res. 2016;2016:3789217. doi: 10.1155/2016/3789217
   PubMed Web of Science ®Google Scholar
• Asnaghi V, Gerhardinger C, Hoehn T, et al. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003;52(2):506–511. doi: 10.2337/diabetes.52.2.506
   PubMed Web of Science ®Google Scholar
• Park DY, Lee J, Kim J, et al. Plastic roles of pericytes in the blood–retinal barrier. Nat Commun. 2017;8(1):15296. doi: 10.1038/ncomms15296
   PubMedGoogle Scholar
• Pfister F, Feng Y, Vom Hagen F, et al. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes. 2008;57(9):2495–2502. doi: 10.2337/db08-0325
   PubMed Web of Science ®Google Scholar
• Romeo G, Liu W-H, Asnaghi V, et al. Activation of nuclear factor-κb induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51(7):2241–2248. doi: 10.2337/diabetes.51.7.2241
   PubMed Web of Science ®Google Scholar
• Oshitari T, Yamamoto S, Hata N, et al. Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy. Br J Ophthalmol. 2008;92:552–556. doi: 10.1136/bjo.2007.132308
   PubMed Web of Science ®Google Scholar
• Oshitari T, Yamamoto S, Roy S. Increased expression of c-Fos, c-Jun and c-Jun N-terminal kinase associated with neuronal cell death in retinas of diabetic patients. Curr Eye Res. 2014;39(5):527–531. doi: 10.3109/02713683.2013.833248
   PubMed Web of Science ®Google Scholar
• Joussen AM, Doehmen S, Le ML, et al. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis. 2009;15:1418–1428.
   PubMed Web of Science ®Google Scholar
• Al-Shabrawey M, Ahmad S, Megyerdi S, et al. Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy. Mol Vis. 2012;18:1895–1906.
   PubMed Web of Science ®Google Scholar
• Abu-El-Asrar AM, Dralands L, Missotten L, et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004;45(8):2760–2766. doi: 10.1167/iovs.03-1392
   PubMed Web of Science ®Google Scholar
• Barber AJ. Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss. Sci China Life Sci. 2015;58(6):541–549. doi: 10.1007/s11427-015-4856-x
   PubMed Web of Science ®Google Scholar
• Wang HJ, Jin YX, Shen W, et al. Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr. 2007;16 Suppl 1:412–417.
   PubMedGoogle Scholar
• Bek T. Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy. Acta Ophthalmol Scand. 1997;75:388–392. doi: 10.1111/j.1600-0420.1997.tb00395.x
   PubMedGoogle Scholar
• Michetti F, Clementi ME, Di Liddo R, et al. The S100Bprotein: a multifaceted pathogenic factor more than a biomarker. Int J Mol Sci. 2023;24(11):9605. doi: 10.3390/ijms24119605
   PubMed Web of Science ®Google Scholar
• Vecino E, Rodriguez FD, Ruzafa N, et al. Glia-neuron interactions in the mammalian retina. Prog Retin Eye Res. 2016;51:1–40. doi: 10.1016/j.preteyeres.2015.06.003
   PubMed Web of Science ®Google Scholar
• Jin N, Gao L, Fan X, et al. Friend or Foe? Resident microglia vs bone marrow-derived microglia and their roles in the retinal degeneration. Mol Neurobiol. 2017;54(6):4094–4112. doi: 10.1007/s12035-016-9960-9
   PubMed Web of Science ®Google Scholar
• Kaur G, Singh NK. The role of inflammation in retinal neurodegeneration and degenerative diseases. Int J Mol Sci. 2021;23:386. doi: 10.3390/ijms23010386
   PubMed Web of Science ®Google Scholar
• LaMoia TE, Shulman GI. Cellular and molecular mechanisms of metformin action. Endocr Rev. 2021;42(1):77–96. doi: 10.1210/endrev/bnaa023
   PubMed Web of Science ®Google Scholar
• Hassan BN, Said AA, Fathalla AS. Ameliorative effect of metformin nano emulsion against induced diabetic nephropathy in rat model: microanatomy study. Adv In Basic And Appl Sci. 2023;1(1):55–62. doi: 10.21608/abas.2023.195731.1010
   Google Scholar
• Kumar S, Bhanjana G, Verma RK, et al. Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release. J Pharm Pharmacol. 2017;69(2):143–150. doi: 10.1111/jphp.12672
   PubMed Web of Science ®Google Scholar